Clinical Trials on Eczema in Japan

Total 119 results

Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Cardiac Edema (CHF)

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)

Diabetic Macular Edema

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)

Carcinomatous Edema

Japan
Shinshu University

Completed

Combination Treatment of Intravitreal Ranibizumab, Focal/Grid Laser and Panretinal Photocoagulation in Patients With Diabetic Macula Edema

Diabetic Macula Edema

Japan
Kagawa University
Novartis Pharmaceuticals

Completed

Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema

Diabetic Macular Edema

Japan
Pfizer

Recruiting

A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Dermavant Sciences GmbH

Completed

A Study of E6005 in Japanese Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Daiichi Sankyo Co., Ltd.

Terminated

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Atopic Dermatitis

Japan
Kyowa Kirin Co., Ltd.

Terminated

Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

Atopic Dermatitis

Japan
Bayer

Completed

Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

Macular Edema

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Atopic Dermatitis (AD)

Japan
Showa University

Completed

The Effect of a Blue Light Filtering IOL

to Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract Surgery

Japan
Novartis

Completed

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Kyowa Kirin Co., Ltd.

Completed

Phase 2 Study of KHK4577

Atopic Dermatitis

Japan
Novartis

Completed

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Bayer

Completed

HPA Axis Study in Japanese Adults

Eczema | Atopic Dermatitis

Japan
Allerderm

Completed

Clinical Evaluation of Metal Panel Allergens: Dose Response Study

Dermatitis, Eczematous

Japan, United States, Germany, Italy, Netherlands, Switzerland
Pfizer

Completed

A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis

Healthy | Atopic Dermatitis

Japan
AbbVie

Recruiting

A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib (ADMIRE)

Atopic Dermatitis

Japan
Kyoto University, Graduate School of Medicine
Novartis

Unknown

Ranibizumab Treatment for Retinal Vein Occlusion

Macular Edema Due to BRVO/CRVO

Japan
Tokyo Medical University

Unknown

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Macular Edema Following Branch Retinal Vein Occlusion

Japan, Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)

Edema | Heart Failure, Congestive

Japan
Dermavant Sciences GmbH

Completed

A Phase 1/2 Study of E6005 in Pediatric Subjects With Atopic Dermatitis

Atopic Dermatitis

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema

Diabetic Macular Edema

Japan
Novartis Pharmaceuticals

Completed

A First-in-Human Study of CEE321 in Adult Subjects

Atopic Dermatitis

United States, Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Pfizer

Completed

Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

Cardiac Edema

Japan
Takeshi Morimoto

Recruiting

GOREISAN for Heart Failure (GOREISAN-HF) Trial (GOREISAN-HF)

Heart Failure | Edema | Clinical Trial | Traditional Japanese Medicine | Kampo Medicine

Japan
Eli Lilly and Company

Recruiting

A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis

Healthy | Atopic Dermatitis

Japan, United States
Janssen Pharmaceutical K.K.

Terminated

A Study of JNJ-39758979 in Adult Japanese Patients With Moderate Atopic Dermatitis

Dermatitis, Atopic

Japan
Mie University

Unknown

Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO (CRVO)

Central Retinal Vein Occlusion

Japan
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

Edema, Cardiac

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Macular Degeneration | Macular Edema | Branch Retinal Vein Occlusion

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) (VIVID-Japan)

Macular Edema

Japan
Sanofi

Completed

Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)

Atopic Dermatitis

Japan
Novartis Pharmaceuticals

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (ZIPANGU)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Japan
Eli Lilly and Company

Completed

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis

United States, Japan
Pfizer

Terminated

A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

Japan
Dermavant Sciences GmbH

Completed

A Phase 2 Study of E6005 in Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Bayer

Completed

Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD)

Atopic Dermatitis

United States, Japan
Novartis

Completed

Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema (REVEAL)

Diabetic Macular Edema

Hong Kong, Taiwan, Singapore, Korea, Republic of, China, Japan
Sanofi
Regeneron Pharmaceuticals

Completed

Dupilumab in Japanese Patients With Atopic Dermatitis

Atopic Dermatitis

Japan

3

Subscribe